90
|
AstraZeneca ltd
high-throughput phh spheroid assay High Throughput Phh Spheroid Assay, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/phh+spheroids/high+throughput+phh+spheroid+assay/pmc07395068-326-5-0 Average 90 stars, based on 1 article reviews
high-throughput phh spheroid assay - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
90
|
AstraZeneca ltd
phh liver spheroid model 2016 or literature alignment), plasma C max.tot values, f u values, MEC and AC 50 values for hLiMT’s and HepaRG spheroids in the high-content screening (HCS) and cellular ATP endpoints" width="250" height="auto" />Phh Liver Spheroid Model, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/phh+spheroids/phh+liver+spheroid+model/pmc07395068-458-11-0 Average 90 stars, based on 1 article reviews
phh liver spheroid model - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
90
|
Medicyte GmbH
phh spheroid model 2016 or literature alignment), plasma C max.tot values, f u values, MEC and AC 50 values for hLiMT’s and HepaRG spheroids in the high-content screening (HCS) and cellular ATP endpoints" width="250" height="auto" />Phh Spheroid Model, supplied by Medicyte GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/phh+spheroids/phh+spheroid+model/10__1016_slash_j__toxlet__2014__06__501-11-7-80 Average 90 stars, based on 1 article reviews
phh spheroid model - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
Image Search Results
2016 or literature alignment), plasma C max.tot values, f u values, MEC and AC 50 values for hLiMT’s and HepaRG spheroids in the high-content screening (HCS) and cellular ATP endpoints" width="100%" height="100%">
Journal: Archives of Toxicology
Article Title: The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development
doi: 10.1007/s00204-020-02763-w
Figure Lengend Snippet: Assigned DILI category (Chen et al.
Article Snippet:
Techniques: Clinical Proteomics, High Content Screening, Tandem Mass Spectroscopy